Gold in innovative science and technology markets, industrial, medical and dental uses. Training and development news

www.science.gold.org

Hello, you either have JavaScript turned off or an old version of Adobe's Flash Player. Get the latest Flash player.

Gold

Scientists solve gold mystery > Gold News > World Gold Council, gold and science, industrial, technological and medical applications

 

Scientists solve gold mystery

The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.

Wednesday, 1st March 2006 (7505 views)

The mystery of how gold helps with ailments such as arthritis might have been solved.

Scientists think they have discovered how certain gold compounds are able to treat autoimmune diseases.

A study at Harvard Medical School found that some types of gold and platinum can strip bacteria and virus particles from key immune system proteins.

Brian BeDecker, a postdoctoral student in the Department of Cell Biology at Harvard Medical School, is the co-author of the study, and reveals that the findings were not entirely expected.

"We were searching for a new drug to treat autoimmune diseases, but instead we discovered a biochemical mechanism that may help explain how an old drug works."

The scientists discovered that cancer drug Cisplatin, which contains platinum, stripped foreign molecules from the MHC class II protein. This led to the discovery that other metals, including a special form of gold, could have the same effect, inactivating all MHC class II proteins.

German doctor Robert Koch found in 1890 that gold killed the bacteria that caused tuberculosis. Thereafter gold came to be used in the treatment of arthritis.

 

« Back to Gold News stories

 

Gold News Archive:

 
 
News provided by Adfero Ltd

Search

Search our Gold Science & Technology content.

  • Gold Spot Price
  • Bid: $1168.10
  • Ask: $1168.90
  • Last Update: 05:27 GMT
© 2009 World Gold Council - all rights reserved. Produced and managed by CFP Group.